OR WAIT null SECS
Amber Salzman, Ph.D., is the president and CEO of Ohana Biosciences.
Startup biotechs need to ensure that life-changing and potentially lifesaving treatments continue to be developed in in the midst of the COVID-19 pandemic. Ohana Biosciences' Amber Salzman outlines how her company is